Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1051-1060 of 2932 for cancer

Edit search filters
  1. Comprehensive Genetic Assessment, Risk And Education In A Mammography Pilot

    Scottsdale/Phoenix, AZ

  2. Study Using Curcumin And Piperine In Reducing Inflammation For Ureteral Stent-Induced Symptoms

    Rochester, MN

  3. Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

    Rochester, MN, Scottsdale/Phoenix, AZ

  4. A Study To Assess The Safety, Tolerability, And Effectiveness Of KPT-9274 To Treat Patients Who Have Advanced Solid Malignancies Or Non-Hodgkin's Lymphoma

    Rochester, MN

  5. A Study Patients With Advanced HCC Undergoing Immunotherapy Through Novel 68Ga PSMA PET Imaging

    Rochester, MN

  6. A Study Of 3-D Digital Mammography To Screen Patients For Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Global Trial In APG2575 For Patients With CLL/​SLL

    Jacksonville, FL

  8. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer

    Rochester, MN

  9. Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing

    Rochester, MN

  10. A Study Of Ripretinib Vs Sunitinib In Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer